Prudential Financial’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.03M Sell
115,402
-166,140
-59% -$1.32M ﹤0.01% 1592
2025
Q4
$1.7M Buy
281,542
+29,208
+12% +$174K ﹤0.01% 1389
2025
Q3
$1.44M Sell
252,334
-358,118
-59% -$1.83M ﹤0.01% 1509
2025
Q2
$3.08M Sell
610,452
-58,337
-9% -$313K ﹤0.01% 1167
2025
Q1
$4.33M Buy
668,789
+424,220
+173% +$3.77M 0.01% 906
2024
Q4
$1.8M Sell
244,569
-180,800
-43% -$1.43M ﹤0.01% 1342
2024
Q3
$3.19M Buy
425,369
+134,300
+46% +$1.17M ﹤0.01% 1221
2024
Q2
$2.59M Buy
291,069
+148,340
+104% +$1.42M ﹤0.01% 1280
2024
Q1
$1.45M Sell
142,729
-322,760
-69% -$3.29M ﹤0.01% 1633
2023
Q4
$4.68M Buy
465,489
+153,420
+49% +$1.4M 0.01% 963
2023
Q3
$2.92M Buy
312,069
+99,655
+47% +$1.42M ﹤0.01% 1156
2023
Q2
$5.21M Sell
212,414
-6,638
-3% -$167K 0.01% 883
2023
Q1
$5.1M Sell
219,052
-39,170
-15% -$1M 0.01% 865
2022
Q4
$6.54M Sell
258,222
-2,495
-1% -$61.2K 0.01% 769
2022
Q3
$5.03M Buy
260,717
+114,505
+78% +$2.91M 0.01% 881
2022
Q2
$3.72M Buy
146,212
+82,555
+130% +$1.93M 0.01% 1045
2022
Q1
$1.64M Buy
63,657
+52,882
+491% +$1.57M ﹤0.01% 1621
2021
Q4
$451K Buy
10,775
+4,420
+70% +$173K ﹤0.01% 2240
2021
Q3
$277K Buy
6,355
+1,530
+32% +$66.2K ﹤0.01% 2355
2021
Q2
$228K Buy
4,825
+260
+6% +$11.8K ﹤0.01% 2414
2021
Q1
$234K Buy
+4,565
New +$246K ﹤0.01% 2359

Other funds holding VIR